Seven Grand Managers’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.44M Buy
+500,000
New +$2.88M 0.09% 104

Other funds holding TSHA

Seven Grand Managers's TSHA Position: Q3 2026 in Review

Seven Grand Managers opened a new position in Taysha Gene Therapies (TSHA) in Q3 2026: 500,000 shares worth $2.44M. The stake represents 0.09% of the portfolio and ranks #104 among its holdings.

205 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.

  • Seven Grand Managers held 500,000 shares of Taysha Gene Therapies worth $2.44M as of Q3 2026.
  • Taysha Gene Therapies was a new Seven Grand Managers position in Q3 2026.
  • Taysha Gene Therapies made up 0.09% of Seven Grand Managers's portfolio in Q3 2026, its #104 holding.
  • 205 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.

Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.